Loading cancer entity…
Loading cancer entity…
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02220855 | A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas | completed | Phase 2 | 14 | Patrick Joseph Loehrer Sr.OTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT03663764 | Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor | unknown | Phase 2 | 57 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2021 | clinicaltrials |
| NCT03449173 |
| Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)(Style) |
| unknown |
| Phase 2 |
| 56 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER |
| 1 |
| Jun 9, 2021 |
| clinicaltrials |
| NCT03613272 | The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum | unknown | N/A | 200 | Jiang FanOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT04554524 | Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma | unknown | Phase 4 | 40 | Tang-Du HospitalOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT04577495 | Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma | completed | — | 50 | IRCCS San RaffaeleOTHER | 0 | Oct 8, 2020 | clinicaltrials |
| NCT02014805 | Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma | unknown | Phase 3 | 210 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT01102192 | The Role of the Thymus in Myasthenia Gravis | completed | — | 20 | Charite University, Berlin, GermanyOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT00921739 | Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies(ESIMRT) | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Apr 2, 2020 | clinicaltrials |
| NCT02636556 | Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors | completed | N/A | 56 | Fudan UniversityOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT01258868 | Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Dec 3, 2019 | clinicaltrials |
| NCT02062632 | Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy | terminated | Phase 2 | 5 | Mayo ClinicOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT00198133 | Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma | completed | Phase 2 | 27 | Patrick Joseph Loehrer Sr.OTHER | 1 | Jul 22, 2019 | clinicaltrials |
| NCT01364727 | A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies | completed | Phase 2 | 33 | Heather WakeleeOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT01301391 | Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy | terminated | Phase 2 | 30 | Tiziana Life Sciences LTDINDUSTRY | 2 | Feb 6, 2019 | clinicaltrials |
| NCT02948855 | Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases | withdrawn | — | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 18, 2018 | clinicaltrials |
| NCT03466827 | Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma(TET-SEL) | unknown | Phase 2 | 25 | Morten Mau-SoerensenOTHER | 2 | Mar 15, 2018 | clinicaltrials |
| NCT03290183 | Confocal Laser Endomicroscopy in Pleural Malignancies | unknown | — | 20 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 21, 2017 | clinicaltrials |
| NCT03288662 | Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors | completed | N/A | 2 | Military Hospital 103OTHER | 0 | Sep 20, 2017 | clinicaltrials |
| NCT01100944 | A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies | terminated | Phase 1 / Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Aug 10, 2017 | clinicaltrials |
| NCT00332969 | Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma | completed | Phase 2 | 25 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 31, 2017 | clinicaltrials |
| NCT03078699 | Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment | completed | N/A | 32 | Third Military Medical UniversityOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT00965250 | Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2016 | clinicaltrials |
| NCT00589290 | Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00718809 | Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2015 | clinicaltrials |
| NCT00387868 | Preoperative Treatment of Patients With High Risk Thymoma | completed | Phase 2 | 21 | Valley Health SystemOTHER | 2 | Dec 9, 2014 | clinicaltrials |
| NCT00369889 | A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer | completed | Phase 2 | 18 | Indiana UniversityOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | terminated | Phase 2 | 39 | Korean Cancer Study GroupOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00965627 | Biology of Thymic Tumors | completed | — | 134 | Istituto Clinico HumanitasOTHER | 1 | Aug 28, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Apr 11, 2022source: clinicaltrials